Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?
Rl. Hong et al., Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?, CLIN CANC R, 5(11), 1999, pp. 3645-3652
Sterically stabilized liposome is characterized by a surface coating of pol
yethylene glycol (PEG) or other polymers that can reduce opsonization of th
e liposome by plasma proteins. It has a higher plasma area under the concen
tration-time curve (AUC), which is believed to correlate with better therap
eutic efficacy. However, the presence of large molecules on the liposomal s
urface may reduce the interactions of liposomes with cells and hinder entry
of liposomes into the tumor tissue. Using a stable liposomal system compos
ed of distearoyl phosphatidylcholine/cholesterol, we examined the effect of
PEG (M-r 2000) on the pharmacokinetics and on the efficacy of liposomal do
xorubicin with C-26 syngeneic tumor model in BALB/c mice. The plasma AUC of
liposomal doxorubicin with 6 mol-% PEG-modified distearoyl phosphatidyleth
anolamine (PEG-DSPE) was approximately twice that of liposomal doxorubicin
without PEG at various dosages, regardless of whether the mice were tumor-b
earing. Paradoxically, the group of mice treated with liposomal doxorubicin
without PEG had higher tumor doxorubicin concentrations. The 72-h tumor AU
C was 1.44 times that of liposomal doxorubicin with 6% PEG-DSPE, The tumor-
accumulation efficiency (AUC(Tumor)/AUC(Plasma)) of liposomal doxorubicin w
ithout PEG was 0.87, and this was more than twice that of the liposomal dox
orubicin with 6% PEG-DSPE (0.31), At a dose of 10 mg/kg, although both lipo
somal groups were better than the free drug group in terms of clinically re
levant parameters, including toxicity, tumor shrinkage, and survival, there
was no difference between the two liposomal drug groups. In this stable li
posome system, surface coating with PEG offered no benefit for liposomal do
xorubicin in the C-26 tumor model. To enhance the therapeutic index of lipo
somal doxorubicin, simply increasing plasma AUC by surface coating with PEG
may not be satisfactory.